Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Bristol

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|July 1, 1996
Determining equivalence and the impact of sample size in anti-infective studies: a point to considerD R Bristol
Journal of Biopharmaceutical Statistics|September 1, 1993
Planning survival studies to compare a treatment to an active controlD R Bristol
Statistics in Medicine|July 1, 1989
Sample sizes for constructing confidence intervals and testing hypothesesD R Bristol
Controlled Clinical Trials|June 1, 1989
Designing clinical trials for two-sided multiple comparisons with a controlD R Bristol
Journal of Biopharmaceutical Statistics|January 1, 1991
A confidence interval for the ratio of treatment variances in a two-by-two crossover studyD R Bristol
Journal of Biopharmaceutical Statistics|September 1, 1993
Sample size determination using an interim analysisD R Bristol
Controlled Clinical Trials|September 1, 1988
A one-sided interim analysis with binary outcomesD R Bristol
Statistics in Medicine|May 1, 1992
The analysis of failure time data in crossover studiesD R Bristol
Journal of Biopharmaceutical Statistics|January 1, 1991
Testing equality of treatment variances in a two-by-two crossover studyD R Bristol
Journal of Biopharmaceutical Statistics|November 27, 1999
Clinical equivalenceD R Bristol
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|July 1, 1996
Determining equivalence and the impact of sample size in anti-infective studies: a point to considerD R Bristol
Journal of Biopharmaceutical Statistics|September 1, 1993
Planning survival studies to compare a treatment to an active controlD R Bristol
Statistics in Medicine|July 1, 1989
Sample sizes for constructing confidence intervals and testing hypothesesD R Bristol
Controlled Clinical Trials|June 1, 1989
Designing clinical trials for two-sided multiple comparisons with a controlD R Bristol
Journal of Biopharmaceutical Statistics|January 1, 1991
A confidence interval for the ratio of treatment variances in a two-by-two crossover studyD R Bristol
Journal of Biopharmaceutical Statistics|September 1, 1993
Sample size determination using an interim analysisD R Bristol
Controlled Clinical Trials|September 1, 1988
A one-sided interim analysis with binary outcomesD R Bristol
Statistics in Medicine|May 1, 1992
The analysis of failure time data in crossover studiesD R Bristol
Journal of Biopharmaceutical Statistics|January 1, 1991
Testing equality of treatment variances in a two-by-two crossover studyD R Bristol
Journal of Biopharmaceutical Statistics|November 27, 1999
Clinical equivalenceD R Bristol
Pageof 2